Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ya‐Chen Tina Shih

Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors

Oncologist

English

Favorable Cardiovascular Health at Young and Middle Ages and Dementia in Older Age—The CHA Study

Journal of the American Heart Association

Cardiovascular Medicine

Cardiology

2019

English

Related publications

Lanreotide vs Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Observational Time and Motion Analysis

Journal of Oncology Pharmacy Practice

English

Octreotide LAR Was Useful for Avoiding Hypoglycemia in an Elderly Patient With Insulinoma

Japanese Journal of Geriatrics

Gerontology

Geriatrics

2017

English

Patterns of Care Among Real‐World Patients With Metastatic Neuroendocrine Tumors

English

Resistance to Octreotide LAR in Acromegalic Patients With High SSTR2 Expression: Analysis of AIP Expression

Arquivos Brasileiros de Endocrinologia & Metabologia

2012

English

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening

Endocrine Abstracts

2016

English

Group Participation and Survival Among Patients With End-Stage Renal Disease.

American Journal of Public Health

English

Treatment With Octreotide in Patients With Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification With Ga-68-Dota-Tate Positron Emission Tomography

Condensed Matter Physics

Imaging

Biotechnology

Biomedical Engineering

2014

English

Catecholamine Production in Patients With Gastroenteropancreatic Neuroendocrine Tumors

European Journal of Endocrinology

English

Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Surgery

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ya‐Chen Tina Shih

Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors

Favorable Cardiovascular Health at Young and Middle Ages and Dementia in Older Age—The CHA Study

Related publications

Lanreotide vs Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Observational Time and Motion Analysis

Octreotide LAR Was Useful for Avoiding Hypoglycemia in an Elderly Patient With Insulinoma

Patterns of Care Among Real‐World Patients With Metastatic Neuroendocrine Tumors

Resistance to Octreotide LAR in Acromegalic Patients With High SSTR2 Expression: Analysis of AIP Expression

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening

Group Participation and Survival Among Patients With End-Stage Renal Disease.

Treatment With Octreotide in Patients With Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification With Ga-68-Dota-Tate Positron Emission Tomography

Catecholamine Production in Patients With Gastroenteropancreatic Neuroendocrine Tumors

Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors